U
Universe Pharmaceuticals Inc
NASDAQ:UPC
Universe Pharmaceuticals Inc
NASDAQ:UPC
Price:
2.86
USD
-1.72%
Market Closed
Market Cap:
$1.6m
Balance Sheet
Balance Sheet Decomposition
Universe Pharmaceuticals Inc
Universe Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Universe Pharmaceuticals Inc
Universe Pharmaceuticals Inc
Balance Sheet
Universe Pharmaceuticals Inc
Universe Pharmaceuticals Inc
Currency: USD
| Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
6
|
3
|
10
|
8
|
6
|
5
|
0
|
34
|
|
| Cash |
6
|
3
|
10
|
8
|
6
|
5
|
0
|
34
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Total Receivables |
8
|
6
|
11
|
16
|
15
|
12
|
17
|
14
|
|
| Accounts Receivables |
8
|
6
|
11
|
16
|
15
|
11
|
13
|
13
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
4
|
1
|
|
| Inventory |
8
|
3
|
2
|
2
|
2
|
3
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
24
|
18
|
4
|
2
|
4
|
|
| Total Current Assets |
22
|
12
|
23
|
50
|
42
|
25
|
52
|
54
|
|
| PP&E Net |
5
|
5
|
4
|
15
|
14
|
13
|
13
|
12
|
|
| PP&E Gross |
5
|
5
|
4
|
15
|
14
|
13
|
13
|
12
|
|
| Accumulated Depreciation |
4
|
4
|
5
|
6
|
6
|
6
|
7
|
7
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
3
|
4
|
3
|
2
|
2
|
|
| Total Assets |
28
N/A
|
18
-36%
|
29
+61%
|
70
+144%
|
60
-15%
|
42
-30%
|
68
+63%
|
69
+2%
|
|
| Liabilities | |||||||||
| Accounts Payable |
3
|
2
|
3
|
5
|
3
|
5
|
5
|
2
|
|
| Accrued Liabilities |
1
|
1
|
0
|
0
|
3
|
3
|
2
|
0
|
|
| Short-Term Debt |
3
|
3
|
4
|
4
|
7
|
5
|
0
|
7
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
2
|
|
| Other Current Liabilities |
12
|
0
|
1
|
1
|
0
|
1
|
8
|
2
|
|
| Total Current Liabilities |
18
|
5
|
8
|
11
|
13
|
14
|
20
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Total Liabilities |
18
N/A
|
5
-70%
|
8
+47%
|
11
+40%
|
13
+17%
|
14
+5%
|
22
+63%
|
13
-41%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Retained Earnings |
5
|
9
|
16
|
28
|
19
|
1
|
8
|
11
|
|
| Additional Paid In Capital |
4
|
4
|
4
|
29
|
29
|
29
|
54
|
63
|
|
| Other Equity |
1
|
0
|
1
|
2
|
2
|
2
|
1
|
2
|
|
| Total Equity |
10
N/A
|
12
+28%
|
21
+68%
|
59
+183%
|
46
-21%
|
28
-40%
|
46
+63%
|
56
+23%
|
|
| Total Liabilities & Equity |
28
N/A
|
18
-36%
|
29
+61%
|
70
+144%
|
60
-15%
|
42
-30%
|
68
+63%
|
69
+2%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
